Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Klowden currently holds 500,000 shares of NKGen Biotech, Inc. (NKGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Klowden has been a net neutral trader of NKGN stock. They have purchased $0 and sold $0 worth of shares.
Michael Klowden's most recent insider trade was on Dec 6, 2024, when they sold 500,000 shares at $0.00 per share.
Michael Klowden serves as Executive at NKGen Biotech, Inc. (NKGN). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Michael Klowden holds the position of Executive at NKGen Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Michael Klowden has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael Klowden was on Dec 6, 2024, when they purchased $0 worth of NKGN shares. This transaction involved 500,000 shares at N/A per share.
Michael Klowden currently owns 500,000 shares of NKGen Biotech, Inc. (NKGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Klowden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Klowden has 3 Form 4 filings on record as an insider at NKGen Biotech, Inc..
Set alerts for Michael Klowden and 40,000+ other insiders.